SCHEMBL15854200

SCHEMBL15854200

N=C(N)NCCCCNC(=O)/C=C/c1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.48
▸ HDAC3 O15379 3/20 0.46
▸ HDAC4 P56524 3/20 0.46
▸ HDAC1 Q13547 3/20 0.46
▸ HDAC7 Q8WUI4 3/20 0.46
▸ HDAC2 Q92769 3/20 0.46
▸ HDAC10 Q969S8 3/20 0.46
▸ HDAC11 Q96DB2 3/20 0.46
▸ HDAC8 Q9BY41 3/20 0.46
▸ HDAC6 Q9UBN7 3/20 0.46
▸ HDAC9 Q9UKV0 3/20 0.46
▸ HDAC5 Q9UQL6 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ GAA P10253 1/20 0.45
▸ EGFR P00533 1/20 0.45
▸ RAB9A P51151 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17219483 0.99 KMT2A (0.47) KMT2AHDAC3HDAC4HDAC1HDAC7
SCHEMBL15854220 0.88 KMT2A (0.51) KMT2AHDAC3HDAC4HDAC1HDAC7
SCHEMBL14490544 0.87 HDAC3 (0.55) KMT2AHDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL17219703 0.86 KMT2A (0.50) KMT2AHDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL17219701 0.86 KMT2A (0.50) KMT2AHDAC3HDAC4HDAC1HDAC7
SCHEMBL30071662 0.83 RAB9A (0.50) HDAC8HDAC6LMNASMN1; SMN2GAA
SCHEMBL5436269 0.83 RAB9A (0.50) HDAC8HDAC6LMNASMN1; SMN2GAA
SCHEMBL15854253 0.83 SMN1; SMN2 (0.52) KMT2AHDAC3HDAC4HDAC1HDAC7
SCHEMBL5436265 0.83 RAB9A (0.50) HDAC8HDAC6LMNASMN1; SMN2GAA
SCHEMBL1711277 0.83 PTPN2 (0.46) KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9540338-B2 Substituted cinnamic acid amides for treating pain NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2017-01-10 — — US disclosed
US-20150322024-A1 Cinnamic Acid Amide Derivative NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-11-12 — — US disclosed
EP-2940003-A1 CINNAMIC ACID AMIDE DERIVATIVE Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2015-11-04 — — EP disclosed
WO-2014104272-A1 CINNAMIC ACID AMIDE DERIVATIVE 日本臓器製薬株式会社 (JP) 2014-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150322024-A1 Cinnamic Acid Amide Derivative OPRL1, TRPV1, TRPA1 KMT2A 1648/4885HDAC3 71/4885HDAC4 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback